Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation

Journal of the Medical Association of Thailand

Volumn 87, Issue 11, 2004, Pages 1380-1384

  Yospaiboon, Yosanan ^a   Luanratanakorn, Patanaree ^a   Noppawinyoowong, Chedsada ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Srinagarind hospital   (Thailand)

Author keywords

Phenylephrine; Pupillary dilation; Side effect

Indexed keywords

EYE DROPS; PHENYLEPHRINE; TROPICAMIDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG FORMULATION; DRUG INSTILLATION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; PUPIL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EYE COLOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYDRIATICS; PHENYLEPHRINE; PUPIL;

EID: 13744259999     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1994: 389-90.
2. McReynolds WU, Havener WH, Henderson JW. Hazards of use of sympathomimetic drugs in ophthalmology. Arch Ophthalmol 1956; 56: 176-9.
3. Fraunfelder FT, Scafidi AF. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol 1978; 85: 447-53.
4. Kumar V, Schoenwald RD, Chien DS, et al. Systemic absorption and cardiovascular effects of phenylephrine eyedrops. Am J Ophthalmol 1985; 99: 180-4.
5. Fraunfelder FT, Meyer SM. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine. Am J Ophthalmol 1985; 99: 362-3.
6. Fraunfelder FT, Meyer SM. Systemic reactions to ophthalmic drug preparation. Med Toxicol 1987; 2: 287-93.
7. Solosko D, Smith RB. Hypertension following 10% phenylephrine ophthalmic. Anesthesiology 1972; 36: 187-9.
8. Wilensky JT, Woodward HJ. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. Am J Ophthalmol 1973; 76: 156-7.
9. Vaughan RW. Ventricular arrhythmia after topical vasocontrictors. Anaesth Analg 1973; 52: 161-5.
10. Rengstorff RH, Doughty CB. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt 1982; 59: 162-77.
11. Neuhaus RW, Hepler RS. Mydriatic effect of phenylephrine 10% (aq) vs phenylephrine 2.5%(aq). Ann Ophthalmol 1980; 12: 1159-60.
12. Tanner V, Casswell AG. A comparative study of the efficacy of 2.5% phenylephrine and 10% phenylephrine in pre-operative mydriasis for routine cataract surgery. Eye 1996; 10: 95-8.
13. Weiss JS, Weiss JN, Greenfield DS. The effects of phenylephrine 2.5% versus phenylephrine 10% on pupillary dilation in patients with diabetes. Retina 1995; 15: 130-3.
14. Duffin RM, Petit TH, Straatsma BR. 2.5% v 10% phenylephrine in maintaining mydriasis during cataract surgery. Arch Ophthalmol 1983; 101: 1903-6.
15. Howard HJ, Lee TP. The effect of instillations of ephedrine solution upon the eyes. Proc Soc Exp Biol Med 1927; 24: 700-2.
16. Chen KK, Poth EJ. The racial difference of the mydriatic action of ephedrine, cocaine, and euphthalmine. Proc Soc Exp Biol Med 1927; 25: 150-1.
17. Angenent WJ, Koelle GB. A possible enzymatic basis for the differential action of mydriatics on light and dark irides. J Physiol 1953; 119: 102-17.
18. Emiru VP. Response to mydriatics in the African. Br J Ophthalmol 1971; 55: 538-43.
19. Chin KW, Laws NM, Chin MK. Phenylephrine drops in ophthalmic surgery: a clinical study on cardiovascular effects. Med J Marlaysia 1994; 49: 158-63.
20. Symons RC, Walland MJ, Kaufman DV. Letter to the editor. Eye 1997; 11: 946-7.
21. Malhotra R, Banerjee G, Brampton W, Price NC. Comparison of the cardiovascular effects of 2.5% phenylephrine and 10% phenylephrine during ophthalmic surgery. Eye 1998; 12: 973-5.